About Genotypic Technology Private Limited
Data last updated: 30 December 2025
Genotypic Technology Private Limited is a private limited company based in Bangalore, Karnataka, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 09 October 1998, the company has been in operation for over 28 years.
Registered with ROC Bangalore under CIN U72200TZ1998PTC008603.
Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25.78 Lakh. It is led by directors Raja Chinnadurai Mugasimangalam and Sudha Narayan Rao.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: No. 259 Apurva 2Nd Floor 4Th Cross 80 Feet Road R. M. V. 2Nd Stage, Bangalore, Karnataka, India – 560094.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.04 Cr, a decline of 25% compared to the previous year.
The company has a workforce of approximately 82 employees as per the latest available data.
The company is associated with 1 brand - Genotypic. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹1.77 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genotypic.co.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressNo. 259 Apurva 2Nd Floor 4Th Cross 80 Feet Road R. M. V. 2Nd Stage, Bangalore, Karnataka, India – 560094
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Genotypic Technology Private Limited
Genotypic Technology Private Limited has one previous CIN (Corporate Identification Number): U72200TZ1998PTC008603. The current CIN is U72200KA1998PTC049038, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200KA1998PTC049038 | Current |
| U72200TZ1998PTC008603 | Previous |
Associated Brands with Genotypic Technology Private Limited
Genotypic Technology Private Limited operates one associated brand: Genotypic. These brands represent Genotypic Technology Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provider of genomics and bioinformatics services | genotypic.co.in |
Competitors & Alternatives of Genotypic Technology Private Limited
Brands and companies operating in the same space as Genotypic Technology Private Limited include Strand Life Sciences, Helix, Benchling and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Strand Life Sciences
|
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | Bengaluru, India, India | 2000 |
Helix
|
Genomic database for clinical research is provided. | San Francisco, United States, United States | 2015 |
Benchling
|
Cloud-based bioinformatics platform is offered for biotech research. | San Francisco, United States, United States | 2012 |
BioAge Labs
|
Bioinformatics platform is provided for biomarkers and drug discovery. | Vallejo, United States, United States | 2015 |
Cellworks
|
Biosimulation platform developed for therapeutic design in life sciences. | San Jose, United States, United States | 2005 |
Inpharmatica
|
Developer of predictive informatics based platform for drug discovery | London, United Kingdom, United Kingdom | 1998 |
ICarbonX
|
Bioinformatics platforms are provided for health management and drug development. | Shenzhen, China, China | 2015 |
Genuity Science
|
AI-based omics data analysis solutions are provided to researchers. | Boston, United States, United States | 2013 |
Business Activity of Genotypic Technology Private Limited
Genotypic Technology Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | ********* |
Board of Directors of Genotypic Technology Private Limited
Genotypic Technology Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Raja Chinnadurai Mugasimangalam
Also directs:
Qtlomics Technologies Private Limited
|
Managing Director | 09 Oct 1998 | 27 Years 9 Months | Current |
|
Sudha Narayan Rao
Also directs:
Dhiti Omics Technologies Private Limited
|
Whole-Time Director | 29 Sep 1999 | 26 Years 9 Months | Current |
Financials of Genotypic Technology Private Limited FY 2024 filings available
Genotypic Technology Private Limited reported revenue of ₹39.04 Cr (down 25% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Genotypic Technology Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Hdfc Bank Limited | ₹14.05 Lakh | Open |
| 14 Dec 2012 | Canara Bank | ₹11.33 Lakh | Open |
| 19 Jul 2008 | Canara Bank | ₹7.25 Cr | Open |
| 30 May 2014 | Siemens Financial Services Private Limited | ₹1.4 Cr | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹2.85 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Genotypic Technology Private Limited
View historical data on people associated with Genotypic Technology Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Genotypic Technology Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Genotypic Technology Private Limited
GSTIN & GST Filing Data of Genotypic Technology Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Genotypic Technology Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Genotypic Technology Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Genotypic Technology Private Limited
MSME Payment Delays by Genotypic Technology Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Genotypic Technology Private Limited
Subsidiaries & Group Companies of Genotypic Technology Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Genotypic Technology Private Limited with ownership details.
MCA Filings & Documents of Genotypic Technology Private Limited
MCA Filings & Documents of Genotypic Technology Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Genotypic Technology Private Limited
Frequently Asked Questions about Genotypic Technology Private Limited
Genotypic Technology Private Limited is an active private limited company in the life sciences sector based in Bangalore, Karnataka, India. It was incorporated on 09 October 1998 (28+ years old) and is registered under CIN U72200KA1998PTC049038. The company has 82 employees.
Genotypic Technology Private Limited reported revenue of ₹39.04 Cr for FY 2025 (down 25.00% YoY).
The current directors of Genotypic Technology Private Limited are:
The primary industry of Genotypic Technology Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Genotypic Technology Private Limited can be reached at the registered office: No. 259 Apurva 2Nd Floor 4Th Cross 80 Feet Road R. M. V. 2Nd Stage, Bangalore, Karnataka, India – 560094, or through the website genotypic.co.in.
The authorised capital is ₹50 Lakh, and the paid-up capital is ₹25.78 Lakh.